CAS 256649-36-2

Formel: C34H46N12O8

InChl: InChI=1S/C34H46N12O8/c35-29(36)41-23-5-1-21(2-6-23)17-39-31(47)43-9-13-45(14-10-43)33(49)53-25-19-51-28-26(20-52-27(25)28)54-34(50)46-15-11-44(12-16-46)32(48)40-18-22-3-7-24(8-4-22)42-30(37)38/h1-8,25-28H,9-20H2,(H,39,47)(H,40,48)(H4,35,36,41)(H4,37,38,42)/t25-,26-,27?,28?/m1/s1

InChI Key: SDKLWMXBZVGUHI-XPALAHHGSA-N

SMILES: C1CN(CCN1C(=O)NCC2=CC=C(C=C2)N=C(N)N)C(=O)O[C@@H]3COC4C3OC[C@H]4OC(=O)N5CCN(CC5)C(=O)NCC6=CC=C(C=C6)N=C(N)N

CRA-2059

CAS: 256649-36-2

CRA-2059

Formel: C₃₄H₄₆N₁₂O₈

Reinheit: ≥95%

Molekulargewicht: 750.82

Ref: 54-BUP23738

CRA-2059

CAS: 256649-36-2

CRA-2059 is a selective and reversible inhibitor of human tryptase beta, exhibiting a Ki value of 620 pM against recombinant human tryptase beta (rHTβ).

Formel: C₃₄H₄₆N₁₂O₈

Reinheit: 97.68% - 99.29%

Farbe und Form: White Solid

Molekulargewicht: 750.82

Ref: TM-T40195